会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Metallopeptide compounds
    • 金属肽化合物
    • US07385025B2
    • 2008-06-10
    • US11188552
    • 2005-07-25
    • Shubh D. SharmaYi-Qun ShiRamesh RajpurohitHui-Zhi CaiMargarita Bastos
    • Shubh D. SharmaYi-Qun ShiRamesh RajpurohitHui-Zhi CaiMargarita Bastos
    • A61K38/04A61K51/08C07K7/00
    • A61K38/04A61K38/105A61K38/34C07K14/68A61K2300/00
    • Metallopeptides with a sequence of a biologically active alpha-melanocyte stimulating hormone (α-MSH), gamma-melanocyte stimulating hormone (γ-MSH), or bombesin sequence of length n residues, wherein a residue including a nitrogen atom and sulfur atom each available for complexation to a metal ion is inserted at any position from between the two and three position to the C-terminus side of the n position, or alternatively is substituted for the residue at any position from the three position to the n position, with a metal ion complexed thereto, with any proline (Pro) residue which is either of the two residues on the immediately adjacent N-terminus side of the inserted or substituent residue comprising a nitrogen atom and sulfur atom available for complexation to a metal ion is substituted with a homolog.
    • 具有生物活性α-黑素细胞刺激激素(α-MSH),γ-黑素细胞刺激激素(γ-MSH)或长度为n个残基的铃蟾肽序列的序列的金属肽,其中包含氮原子和硫原子的残基各自可用 用于与金属离子的络合被插入到位于n位置的两个和三个位置到C末端侧的任何位置处,或者替代地在从三个位置到n个位置的任何位置处的残基代替, 金属离子与其中包含可与金属离子络合的氮原子和硫原子的插入或取代残基的直接相邻的N末端侧的两个残基中的任一种的脯氨酸(Pro)残基替换为 同系物
    • 4. 发明授权
    • Knockout identification of target-specific sites in peptides
    • 敲除肽中靶特异性位点的鉴定
    • US07351690B2
    • 2008-04-01
    • US10769695
    • 2004-01-30
    • Shubh D. SharmaYi-Qun ShiMargarita BastosRamesh RajpurohitHui-Zhi Cai
    • Shubh D. SharmaYi-Qun ShiMargarita BastosRamesh RajpurohitHui-Zhi Cai
    • A61K38/16
    • C07K5/1008C07K1/047C07K5/1016C07K5/1024G01N33/6803
    • The invention provides methods for identification and determination of target-specific sites in peptides and proteins, including a method for determining the primary sequence of a secondary structure within a known parent polypeptide that binds to the target of interest. In one embodiment of the invention, a residue or mimetic containing a nitrogen atom and a sulfur atom available for binding to a metal ion is serially substituted for single residues in or inserted between adjacent residues in a known primary sequence of a peptide or protein. The resulting sequence is complexed with a metal ion thereby forming a metallopeptide. The resulting metallopeptides are then used in binding or functional assays related to the target of interest, and the metallopeptide(s) which result in significant or substantially decreased or changed binding or functionality are determined to identify the primary sequence involved in such binding or functionality.
    • 本发明提供用于鉴定和确定肽和蛋白质中靶特异性位点的方法,包括确定结合目的靶标的已知亲本多肽内的二级结构的一级序列的方法。 在本发明的一个实施方案中,含有可与金属离子结合的氮原子和硫原子的残基或模拟物连续取代肽或蛋白质的已知一级序列中相邻残基之间或插入其中的单个残基。 所得到的序列与金属离子络合,从而形成金属肽。 然后将所得金属肽用于与感兴趣靶标相关的结合或功能测定,并确定导致显着或显着降低或改变的结合或功能的金属肽,以鉴定涉及这种结合或功能的一级序列。
    • 9. 发明申请
    • Substituted melanocortin receptor-specific piperazine compounds
    • 取代的黑皮质素受体特异性哌嗪化合物
    • US20050176728A1
    • 2005-08-11
    • US11099814
    • 2005-04-05
    • Shubh SharmaYi-Qun ShiRamesh RajpurohitZhijun Wu
    • Shubh SharmaYi-Qun ShiRamesh RajpurohitZhijun Wu
    • A61K31/496C07D43/02
    • C07D241/04C07D403/06
    • Melanocortin receptor-specific compounds of the general formulas and pharmaceutically acceptable salts thereof, where J is a substituted or unsubstituted monocyclic or bicyclic ring structure, L is a linker, W is a heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, Q includes a substituted or unsubstituted aromatic carbocyclic ring, R6, R7, y and z are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration, and optionally with one or two additional ring substituents as defined, which compounds bind to one or more melanocortin receptors and are optionally an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.
    • 其中J为取代或未取代的单环或双环结构的黑皮质素受体特异性化合物及其药学上可接受的盐,L为连接基,W为至少一个阳离子中心,氢键供体或氢的杂原子单元 键接受体,Q包括取代或未取代的芳族碳环,R 6,R 7,y和z如说明书中所定义,并且用 星号可以具有任何立体化学构型,并且任选地具有如所定义的一个或两个另外的环取代基,这些化合物结合一种或多种黑皮质素受体,并且任选地是激动剂,部分激动剂,拮抗剂,反向激动剂或逆反应的拮抗剂 激动剂,并且可以用于治疗一种或多种黑皮质素受体相关病症或病症,以及使用本发明化合物的方法。